Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

At the Kirishi refinery shut down key unit

9/15/25 SNGS

MAX launched digital ID in pilot mode

9/15/25 VKCO

Magnit and Stars Coffee opened the first Red Stars coffee point

9/15/25 MGNT

Delimobil has launched car rental through its website

9/15/25 DELI

X5 introduces its own ready-to-eat quality label

9/15/25 X5

Pprosecutor's office demands to demolish the YUGK workshops in the Plastovsky district

9/15/25 UGLD

Shareholders of Yandex approved dividends

9/15/25 YDEX

Legal entity of the Nau Engine game engine is in liquidation

9/15/25 VKCO

Fix Price started buyback

9/15/25 FIXR

Ozon Pharmaceuticals has launched the Immunotresan drug on the market

9/15/25 OZPH